Kentucky settles lawsuit with Purdue Pharma for $24 million

Purdue Pharma, the maker of oxycodone hydrochloride (OxyContin) will pay Kentucky $24 million over the next 8 years as part of the settlement of a lawsuit that accused the company of misleading the public about the addictiveness of the powerful prescription drug. The state first filed the lawsuit against Purdue Pharma in 2007.

Purdue Pharma, the maker of oxycodone hydrochloride (OxyContin) will pay Kentucky $24 million over the next 8 years as part of the settlement of a lawsuit that accused the company of misleading the public about the addictiveness of the powerful prescription drug. The state first filed the lawsuit against Purdue Pharma in 2007. The company has had FDA approval since 1995 to market the drug. Kentucky officials accused Purdue Pharma of marketing the prescription opioid analgesic as nonaddictive because it was a drug that, when swallowed, slowly released the drug over 12 hours. However, users soon discovered if they crushed the medicine, the drug lost its time release qualities and created an instant high. State officials said that led to a wave of addiction and increased medical costs across the state. Purdue Pharma replaced the drug with a new version in 2010 that deters abuse. The state Supreme Court was still considering whether Purdue Pharma missed a deadline to dispute the facts of the case. Purdue Pharma did not admit any wrongdoing in the settlement agreement.